SLC2A12 and breast cancer: GLUT12 was originally cloned from the human breast cancer cell line, MCF7, and its expression was found to be stronger in ductal cell carcinoma than in benign ducts of breast cancer tissues [59], indicating a possible role in glucose uptake in breast cancer tissue.